Published in Br J Gen Pract on September 01, 2006
Quality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta-analysis and meta-regression. Thromb J (2014) 0.92
Performance of stroke risk scores in older people with atrial fibrillation not taking warfarin: comparative cohort study from BAFTA trial. BMJ (2011) 0.90
Practice nursed-based, individual and video-assisted patient education in oral anticoagulation--protocol of a cluster-randomized controlled trial. BMC Fam Pract (2011) 0.86
Systematic review of observational studies assessing bleeding risk in patients with atrial fibrillation not using anticoagulants. PLoS One (2014) 0.77
Measures of vitamin K antagonist control reported in atrial fibrillation and venous thromboembolism studies: a systematic review. BMJ Open (2014) 0.76
Potential impact of new oral anticoagulants on the management of atrial fibrillation-related stroke in primary care. Int J Clin Pract (2013) 0.75
Warfarin for atrial fibrillation. Br J Gen Pract (2006) 0.75
A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost (1993) 7.92
Use of warfarin in non-rheumatic atrial fibrillation: a commentary from general practice. Br J Gen Pract (1995) 6.43
Anticoagulant prophylaxis against stroke in atrial fibrillation: effectiveness in actual practice. CMAJ (1999) 3.12
Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. JAMA (2002) 2.94
The impact of long-term warfarin therapy on quality of life. Evidence from a randomized trial. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. Arch Intern Med (1991) 2.92
Trends in the prevalence of diagnosed atrial fibrillation, its treatment with anticoagulation and predictors of such treatment in UK primary care. Heart (2005) 2.24
Risks of oral anticoagulant therapy with increasing age. Arch Intern Med (2005) 2.06
Oral anticoagulation and hemorrhagic complications in an elderly population with atrial fibrillation. Arch Intern Med (2001) 1.82
Are the results of randomized controlled trials on anticoagulation in patients with atrial fibrillation generalizable to clinical practice? Arch Intern Med (2001) 1.67
Evaluation of risk factors for stroke/embolism and of complications due to anticoagulant therapy in atrial fibrillation. Stroke (2001) 1.54
Lessons from the Stroke Prevention in Atrial Fibrillation trials. Ann Intern Med (2003) 1.41
A systematic review of outcome measures reported for the therapeutic effectiveness of oral anticoagulation. J Clin Pathol (2003) 1.07
Does the Birmingham model of oral anticoagulation management in primary care work outside trial conditions? Br J Gen Pract (2001) 1.06
Oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and risk of bleeding. A Multicenter Inception Cohort Study. Thromb Haemost (2001) 1.02
Comorbidity associated with atrial fibrillation: a general practice-based study. Br J Gen Pract (2001) 0.98
Dependency rather than old age increases the risk of warfarin-related bleeding. Br J Gen Pract (2004) 0.96
Anticoagulant treatment of patients in Swedish primary health care. Safety aspects. Eur J Clin Pharmacol (2001) 0.95
Outcomes in the management of atrial fibrillation: clinical trial results can apply in practice. Intern Med J (2001) 0.92
Anticoagulant treatment of patients with atrial fibrillation in primary health care. Scand J Prim Health Care (1999) 0.87
Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population [ISRCTN89345269]. BMC Cardiovasc Disord (2003) 0.85
Warfarin for nonvalvular atrial fibrillation in primary care--another example of the age paradox? J Cardiovasc Risk (2001) 0.84
Warfarin therapy for atrial fibrillation: the patient's preference is important. Arch Intern Med (2000) 0.80
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet (2002) 17.19
Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation (2003) 5.70
C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes (2002) 3.59
Effect of pravastatin on cardiovascular events in people with chronic kidney disease. Circulation (2004) 2.33
Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT): a randomised, double-blind, placebo-controlled study and meta-analysis. Lancet (2009) 2.28
Should hospitals provide all patients with single rooms? BMJ (2013) 2.22
A randomized trial comparing treatments for varicose veins. N Engl J Med (2014) 2.20
Effect of pravastatin on rate of kidney function loss in people with or at risk for coronary disease. Circulation (2005) 2.13
Short- and long-term changes in plasma inflammatory markers associated with preeclampsia. Hypertension (2004) 1.92
Mortality in adults with newly diagnosed and chronic epilepsy: a retrospective comparative study. Lancet Neurol (2006) 1.83
Chronic beta-adrenoceptor blockade and human atrial cell electrophysiology: evidence of pharmacological remodelling. Cardiovasc Res (2003) 1.78
Observation or operation for patients with an asymptomatic inguinal hernia: a randomized clinical trial. Ann Surg (2006) 1.73
Atrial cellular electrophysiological changes in patients with ventricular dysfunction may predispose to AF. Heart Rhythm (2008) 1.72
Internal limiting membrane peeling versus no peeling for idiopathic full-thickness macular hole: a pragmatic randomized controlled trial. Invest Ophthalmol Vis Sci (2011) 1.66
Predictors of pharmacoresistant epilepsy. Epilepsy Res (2007) 1.65
Post-operative atrial fibrillation is influenced by beta-blocker therapy but not by pre-operative atrial cellular electrophysiology. J Cardiovasc Electrophysiol (2006) 1.65
Population-based trends in pregnancy hypertension and pre-eclampsia: an international comparative study. BMJ Open (2011) 1.64
Should diabetes be considered a coronary heart disease risk equivalent?: results from 25 years of follow-up in the Renfrew and Paisley survey. Diabetes Care (2005) 1.52
Renal replacement therapy in the over-80s. Age Ageing (2005) 1.46
The effectiveness of cognitive behavior therapy for borderline personality disorder: results from the borderline personality disorder study of cognitive therapy (BOSCOT) trial. J Pers Disord (2006) 1.46
Potassium disorders--clinical spectrum and emergency management. Resuscitation (2006) 1.45
Longitudinal study of genital infection by herpes simplex virus type 1 in Western Scotland over 15 years. BMJ (2002) 1.37
Renal impairment after high-dose flucloxacillin and single-dose gentamicin prophylaxis in patients undergoing elective hip and knee replacement. Nephrol Dial Transplant (2012) 1.31
The "PRIM" study: a randomized comparison of prostaglandin E2 gel with the nitric oxide donor isosorbide mononitrate for cervical ripening before the induction of labor at term. Am J Obstet Gynecol (2006) 1.11
Using patient-reported outcomes in schizophrenia: the Scottish Schizophrenia Outcomes Study. Psychiatr Serv (2009) 1.10
The role of covariates in estimating treatment effects and risk in long-term clinical trials. Stat Med (2002) 1.08
A pragmatic randomised, controlled trial of intensive care follow up programmes in improving longer-term outcomes from critical illness. The PRACTICAL study. BMC Health Serv Res (2007) 1.07
A Prospective Study of Pravastatin in the Elderly at Risk (PROSPER): Screening Experience and Baseline Characteristics. Curr Control Trials Cardiovasc Med (2002) 1.07
The cost-effectiveness of cognitive behavior therapy for borderline personality disorder: results from the BOSCOT trial. J Pers Disord (2006) 1.06
A randomized controlled trial of cognitive behavior therapy for borderline personality disorder: rationale for trial, method, and description of sample. J Pers Disord (2006) 1.04
Trial protocol OPPTIMUM-- does progesterone prophylaxis for the prevention of preterm labour improve outcome? BMC Pregnancy Childbirth (2012) 1.03
Are there socioeconomic differences in responses to a commonly used self report measure of chronic illness? Int J Epidemiol (2005) 1.02
Effect of pravastatin in people with diabetes and chronic kidney disease. J Am Soc Nephrol (2005) 1.02
Cognitive therapy v. usual treatment for borderline personality disorder: prospective 6-year follow-up. Br J Psychiatry (2010) 0.95
Exploring change processes in compassion focused therapy in psychosis: results of a feasibility randomized controlled trial. Br J Clin Psychol (2012) 0.94
Recruitment to publicly funded trials--are surgical trials really different? Contemp Clin Trials (2008) 0.94
Recovery of renal function after 90 d on dialysis: implications for transplantation in patients with potentially reversible causes of renal failure. Clin Transplant (2008) 0.91
A mobile phone intervention to reduce binge drinking among disadvantaged men: study protocol for a randomised controlled cost-effectiveness trial. Trials (2014) 0.91
Mortality in epilepsy. Epilepsy Behav (2007) 0.90
A novel dietary intervention to optimize vitamin E intake of pregnant women to 15 mg/day. J Acad Nutr Diet (2012) 0.90
Usefulness of fractional flow reserve to improve diagnostic efficiency in patients with non-ST elevation myocardial infarction. Am J Cardiol (2012) 0.90
WISECARE+: Results of a European study of a nursing intervention for the management of chemotherapy-related symptoms. Eur J Oncol Nurs (2008) 0.87
The prevalence, nature, and importance of hematologic abnormalities in heart failure. Am Heart J (2006) 0.87
Visual art in hospitals: case studies and review of the evidence. J R Soc Med (2010) 0.87
Nephrotic syndrome presenting as deep vein thrombosis or pulmonary embolism. Emerg Med J (2008) 0.86
IMOP: randomised placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour - clinical trial with analyses of efficacy, cost effectiveness and acceptability. BMC Pregnancy Childbirth (2006) 0.86
Impact of visual art in patient waiting rooms: survey of patients attending a transplant clinic in Dumfries. JRSM Short Rep (2010) 0.84
Emergency medical admissions, deaths at weekends and the public holiday effect. Cohort study. Emerg Med J (2013) 0.84
The home as an appropriate setting for women undertaking cervical ripening before the induction of labour. Midwifery (2010) 0.82
A pragmatic multi-centre randomised controlled trial of fluid loading in high-risk surgical patients undergoing major elective surgery--the FOCCUS study. Crit Care (2011) 0.82
A feasibility randomised controlled trial of the New Orleans intervention for infant mental health: a study protocol. ScientificWorldJournal (2013) 0.81
Ximelagatran compared with warfarin for the prevention of systemic embolism and stroke. An imputed placebo analysis. Cardiovasc Drugs Ther (2005) 0.80
Comparison of estimated protein output and urine protein: creatinine ratio in first and second voids with 24-hour urine protein. Nephron Extra (2011) 0.79
Impact and influences on caregiver outcomes at one year post-stroke. Cerebrovasc Dis (2004) 0.79
Bilateral renovascular disease causing cardiorenal failure. BMJ (2003) 0.79
Fulminating varicella despite prophylactic immune globulin and intravenous acyclovir in a renal transplant recipient: should renal patients be vaccinated against VZV before transplantation? Clin Transplant (2006) 0.79
Power and sample size for cost-effectiveness analysis: fFN neonatal screening. Contemp Clin Trials (2011) 0.78
Designing and implementing E-health Applications in the UK's National Health Service. J Health Commun (2005) 0.77
Risky single-occasion drinking and disadvantaged men: will recruitment through primary care miss hazardous drinkers? Alcohol Clin Exp Res (2013) 0.76
Study of progesterone for the prevention of preterm birth in twins (STOPPIT): findings from a trial-based cost-effectiveness analysis. Int J Technol Assess Health Care (2010) 0.76
Looking for prognostic information in the ST-T segment--is it really worth it? J Electrocardiol (2004) 0.75
Metabolic syndrome and diabetes mellitus. Circulation (2004) 0.75
Feeling bad and risk of stroke. J Hypertens (2003) 0.75
Hypokalaemia: common things occur commonly - a retrospective survey. JRSM Short Rep (2012) 0.75
RApid Primary care Initiation of Drug treatment for Transient Ischaemic Attack (RAPID-TIA): study protocol for a pilot randomised controlled trial. Trials (2013) 0.75
Assessing catheter-associated urinary tract infection - Authors' reply. Lancet (2013) 0.75
Treatment of vitamin D deficiency: divergence between clinical practice and expert advice. Postgrad Med J (2012) 0.75
Risks of coronary angiography. Lancet (2005) 0.75
Chronic kidney disease presenting acutely: presentation, clinical features and outcome of patients with irreversible chronic kidney disease who require dialysis immediately. Postgrad Med J (2010) 0.75
17ss oestradiol does not attenuate the response to angiotensin I and II during long term therapy in postmenopausal women. Cardiovasc Drugs Ther (2004) 0.75